Results 141 to 150 of about 28,157 (212)

Determinants of antibody responses to two doses of ChAdOx1 nCoV-19 or BNT162b2 and a subsequent booster dose of BNT162b2 or mRNA-1273: population-based cohort study (COVIDENCE UK) [PDF]

open access: gold, 2022
David A. Jolliffe   +17 more
openalex   +1 more source

Supraclavicular lymphadenopathy secondary to COVID-19 BNT162b2 vaccine

open access: yesJournal of Postgraduate Medicine, 2021
Roca, B, Rambla, M, Roca, M Manuel
openaire   +2 more sources

Longitudinal cellular and humoral immune responses after triple BNT162b2 and fourth full-dose mRNA-1273 vaccination in haemodialysis patients [PDF]

open access: gold, 2022
Matthias Becker   +19 more
openalex   +1 more source

New onset of pemphigus foliaceus following BNT162b2 vaccine [PDF]

open access: yesDermatologic Therapy, 2022
Şebnem Yıldırıcı   +3 more
openaire   +3 more sources

Individual vaccine efficacy variation with time since mRNA BNT162b2 vaccination estimated by rapid, quantitative antibody measurements from a finger-prick sample [PDF]

open access: gold, 2021
Matheus J. T. Vargas   +19 more
openalex   +1 more source

CoronaVac or BNT162b2 Vaccine as a Third Dose

open access: yesAmerican Journal of Respiratory and Critical Care Medicine, 2022
Rujittika Mungmunpuntipantip   +1 more
openaire   +2 more sources

Cutaneous reaction to BNT162b2 mRNA COVID‐19 vaccine [PDF]

open access: yesInternational Journal of Dermatology, 2021
Alba López‐Valle   +2 more
openaire   +3 more sources

Anti-SARS-CoV-2 RBD IgG responses in convalescent versus naïve BNT162b2 vaccine recipients

open access: green, 2021
Lorenzo Azzi   +4 more
openalex   +2 more sources

Incidences of Adverse Reactions in BNT162b2: A Meta-analysis [PDF]

open access: gold, 2022
Yi Dong   +5 more
openalex   +1 more source

Decline of immune humoral response after BNT162b2 vaccine

open access: yesJournal of Infection, 2022
Sonia Ferri   +8 more
openaire   +4 more sources

Home - About - Disclaimer - Privacy